Company Warned Over Human Placenta Product
MedPage Today) — The FDA has warned MiMedx that its wound-healing product derived from human placentas needs agency approval before it can be sold to doctors and hospitals.
In its warning letter to CEO Joseph Capper, FDA said the company’s Axiofill…
Read More
0
